Sign in

CIK 0001001316

  • Large accelerated filer

TG THERAPEUTICS, INC.

Sign in to watch
Ticker
TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363898269
Phone
+1 212-554-4484
Business address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
Former names
MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$274,800
in 1 filing

Net −$274,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Charney Laurence N −$275K Director sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2008-09-11 Herskowitz Neil Director Grant or award · Warrant +24,000 24,000
2008-09-11 ABEL DOUGLAS President and CEO Grant or award · Warrant +24,000 24,000
2008-03-25 MCINERNEY TIMOTHY Director Grant or award · Stock Options +75,000 75,000
2008-03-25 Steinhart Richard I Director Grant or award · Stock Options +75,000 75,000
2008-03-25 ABEL DOUGLAS President and CEO Grant or award · Stock Options +1,300,000 1,300,000
2008-03-25 Herskowitz Neil Director Grant or award · Stock Options +75,000 75,000
2008-03-25 McGuinness Michael Chief Financial Officer Grant or award · Stock Options +1,100,000 1,100,000
2008-03-25 WEISER MICHAEL Director Grant or award · Stock Options +75,000 75,000
2008-03-25 Hoenlein Malcolm Director Grant or award · Stock Options +75,000 75,000
2007-08-01 ABEL DOUGLAS Chief Executive Officer Grant or award +10,000 $0.27 $3K 45,000
2007-08-01 WEISER MICHAEL Director Grant or award +10,000 $0.26 $3K 2,247,563
2007-07-20 ABEL DOUGLAS President and CEO Grant or award +10,000 $0.36 $4K 45,000
2007-07-16 WEISER MICHAEL Director Grant or award +10,000 $0.33 $3K 2,237,563
2007-07-13 ABEL DOUGLAS President and CEO Grant or award +5,000 $0.34 $2K 35,000
2007-07-13 McGuinness Michael Chief Financial Officer Grant or award +10,000 $0.34 $3K 10,000
2007-07-12 WEISER MICHAEL Director Grant or award +10,000 $0.38 $4K 2,227,563
2007-04-25 McGuinness Michael Chief Financial Officer Grant or award · Stock Options +320,000 320,000
2007-04-25 HARRIS ALAN G Chief Medical Officer Grant or award · Stock Options +300,000 300,000
2007-04-25 ABEL DOUGLAS President and CEO Grant or award · Stock Options +250,000 250,000
2007-03-30 Herskowitz Neil Director Purchase +55,555 $0.90 $50K 77,288

Page 12 of 13 · 253 trades